Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference50 articles.
1. Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies;Orlowski;J Clin Oncol,2002
2. A phase 2 study of bortezomib in relapsed, refractory myeloma;Richardson;N Engl J Med,2003
3. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma;Jagannath;Br J Haematol,2004
4. Bortezomib or highdose dexamethasone for relapsed multiple myeloma;Richardson;N Engl J Med,2005
5. Bortezomib Demonstrates Superior Survival Compared With High Dose Dexamethasone and Higher Response Rates after Extended Follow up in the APEX Trial in Relapsed Multiple Myeloma;Richardson,2006
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献